MTOR and neoplasm: Application of GSEA showed that within each of PCS1, PCS2 and PCS3, HER2+ tumors were enriched for, e.g., MYC targets, and mTOR signaling in comparison to HER2− tumors, providing further evidence that HER2 status and BCCS provide independent information on tumor biology.